Synergistic growth in Cipla Ltd

As the global markets are trembling with the fear of Coronavirus, the pharmaceutical industry has been performing well in the weaker market. The Nifty Pharma stocks are displaying bullish trend in the market as the Pharma index was up by 2.10% at 8,086 during the end of the session. Also, with the fall in rupee to Rs.72.74 as it edged lower against dollar was also a major event for the bullish trend as it would result in the increase of their exports. The company’s stock has been rising since the fall in rupee which indicates the revenue being generated by the company in exports and also with the increase in the fear of Coronavirus, the sales of generic medicines have increased along with the preventive measures of the people.

The Q3 profits of the company also posted a 5.7% hike in net profits to Rs.351 crore which signifies the capacity of its business operations and also the company holds key market share in the US generics market. The following chart shows the change in trend of the stock as the fall in rupee value against dollar was a bullish signal for few IT and Pharmaceutical stocks during the day. The supertrend shows a bullish trend in the stock even after there was a bearish candlestick of previous day’s session, but the market opened today with bullish sentiment for the stock.
 

The trend of the stock tend to be continued as bullish since the effect of the Coronavirus and the fall in rupee value would continue to have an impact on the global market and would contribute to the sales of pharmaceutical companies. The following chart of parabolic SAR shows that the bullish trend of the company continues and also the candlestick formed currently are close to the moving average of the stock price. 
 

The Government has also taken reforms to boost the economic slowdown by approving Indian companies to directly list in the overseas stock exchanges which would also increase the market capitalization of companies operating in developed markets such as US, Britain, Japan etc.., The companies having presence in US and other markets would be able to issue their shares through respective stock exchanges which would also boost the brand image of the company. As the government reforms would work in the long-run, currently the Nifty Pharma has been performing well with their leading stocks such as Sun Pharma and Cipla which are the best place to invest money and expect good returns in the current economic conditions.

Comments

Popular posts from this blog

WHAT'S IT LIKE TO LIVE IN THE HOSTELS OF CHRIST LAVASA?

PANEL DISCUSSION ON LEADERSHIP & ENTREPRENEURSHIP DEVELOPMENT SKILLS

WEBINAR ON ROLE OF DIGITAL MARKETING IN THE PHARMACEUTICAL SECTOR